News & stories – CEPI

Latest news

Filter by category:

FILTER: ALL CATEGORIESFilter by:

Latest news

The importance of blood markers in assessing vaccine efficacy

If vaccine efficacy can’t be assessed through placebo-controlled trials in future, how can we know if they are effective?

Outbreaks

ProMED: Pneumonia cases of unknown cause in Wuhan, China

The World Health Organization is working with national authorities in China on pathogen identification and monitoring of patients. Suspected cases have also been reported in Hong Kong. MERS, SARS and influenza have been ruled out. ProMED reports.

ProMED: MERS cases reported in Doha, Qatar

ProMED: Ebola cases spike in DRC after security issues disrupt response efforts

Cases of MERS have also been confirmed in Saudi Arabia and Lassa fever in Nigeria. By ProMED.

Other news

CEPI-supported COVID-19 vaccine, developed by University of Oxford/ AstraZeneca, receives authorisation in the UK

Statement from Dr. Richard Hatchett, CEO of CEPI, welcoming the announcement from the UK’s independent regulatory authority, MHRA

CEPI partners with Biological E Limited to advance development and manufacture of COVID-19 vaccine candidate

CEPI will initially contribute up to $5m toward the cost of scaling up the manufacturing process.

Coming soon: Call to join CEPI’s Scientific Advisory Committee

The expert group provides guidance on CEPI’s vaccine programmes as we work on ongoing and future infectious disease outbreaks.

COVAX announces additional deals to access promising COVID-19 vaccine candidates; plans global rollout starting Q1 2021

Largest-ever Lassa fever research programme launches in West Africa

New research programme, ‘Enable’, aims to increase knowledge of the disease and assess true case count of those infected across the region.

Equitable access to vaccines is the best way out of COVID-19

How CEPI is enabling access to COVID-19 vaccines

Twitter

Follow

Tweets by CEPIvaccines

Media enquiries

Get involved in our cause

Become a partner